The combined assessment of PR, ER, AR, GATA3, and PD-L1—as a manually predefined five-marker prognosis score—showed strong prognostic relevance (p < 0.0001, Figure 5C) and was an independent risk factor (p = 0.0034) in a multivariate analysis including pT, pN, and tumor grade. The gene discussed is CD274; the disease is neoplasm.